• Mashup Score: 0

    Vera Bril, MD, Professor of Medicine at the University of Toronto discusses rozanolixizumab’s treatment mechanism to treat myasthenia gravis.

    Tweet Tweets with this article
    • Vera Bril, MD, Professor of Medicine at the University of Toronto, discusses rozanolixizumab’s treatment mechanism to treat myasthenia gravis #checkrare #myastheniagravis @MGNet__ @MyastheniaOrg https://t.co/vdFJ06UloW